C16ORF75 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.688200E-01
Normal-vs-Stage2
7.817200E-01
Normal-vs-Stage3
1.665440E-01
Normal-vs-Stage4
6.928400E-01
Stage1-vs-Stage2
2.316800E-01
Stage1-vs-Stage3
6.144600E-01
Stage1-vs-Stage4
8.476000E-01
Stage2-vs-Stage3
1.386630E-01
Stage2-vs-Stage4
4.419200E-01
Stage3-vs-Stage4
4.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.966400E-01
Normal-vs-AfricanAmerican
9.516400E-01
Normal-vs-Asian
4.233800E-01
Caucasian-vs-AfricanAmerican
7.896600E-01
Caucasian-vs-Asian
4.380400E-02
AfricanAmerican-vs-Asian
6.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.728000E-01
Normal-vs-Female
8.251400E-01
Male-vs-Female
2.981000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.244200E-01
Normal-vs-Age(41-60Yrs)
8.449800E-01
Normal-vs-Age(61-80Yrs)
9.859200E-01
Normal-vs-Age(81-100Yrs)
7.738000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.517800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.098200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.318400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.829200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.758600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.032000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.606000E-01
Normal-vs-Daily Drinker
7.751800E-01
Normal-vs-Weekly Drinker
7.778400E-01
Normal-vs-Occasional Drinker
9.822800E-01
Normal-vs-Social Drinker
8.495600E-01
Non Drinker-vs-Daily Drinker
8.121400E-01
Non Drinker-vs-Weekly Drinker
7.779600E-01
Non Drinker-vs-Occasional Drinker
6.849200E-01
Non Drinker-vs-Social Drinker
9.703000E-01
Daily Drinker-vs-Weekly Drinker
9.349200E-01
Daily Drinker-vs-Occasional Drinker
5.420400E-01
Daily Drinker-vs-Social Drinker
8.693200E-01
Weekly Drinker-vs-Occasional Drinker
5.553600E-01
Weekly Drinker-vs-Social Drinker
8.337800E-01
Occasional Drinker-vs-Social Drinker
6.952200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.934800E-01
Normal-vs-Grade 2
6.843400E-01
Normal-vs-Grade 3
7.440200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.760970E-03
Grade 1-vs-Grade 3
9.54909999999476E-05
Grade 1-vs-Grade 4
5.934800E-01
Grade 2-vs-Grade 3
8.449900E-02
Grade 2-vs-Grade 4
6.843400E-01
Grade 3-vs-Grade 4
7.440200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.517000E-01
Normal-vs-NonDiabetic
8.186200E-01
Diabetic-vs-NonDiabetic
2.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.679200E-01
Normal-vs-NoPancreatitis
9.292400E-01
Pancreatitis-vs-NoPancreatitis
7.331900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.589200E-01
Normal-vs-N1
8.186800E-01
N0-vs-N1
3.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.891030E-01
Normal-vs-TP53-NonMutant
8.722000E-01
TP53-Mutant-vs-TP53-NonMutant
1.58770000036057E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
